Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | AHR | P35869 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | CNR2 | P34972 | 6/20 | 0.34 |
| ▸ | CNR1 | P21554 | 5/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | TPMT | P51580 | 1/20 | 0.31 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.31 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL803437 | 0.79 | TSHR (0.50) | TSHRTP53CYP3A4MEN1KMT2A | |
| SCHEMBL673309 | 0.79 | TSHR (0.50) | TSHRTP53CYP3A4AHRMEN1 | |
| SCHEMBL45127 | 0.77 | GABRA1 (0.40) | TSHRCYP3A4ALDH1A1 | |
| SCHEMBL9403849 | 0.77 | TSHR (0.47) | TSHRTP53CYP3A4AHRMEN1 | |
| SCHEMBL16396157 | 0.75 | ALDH1A1 (0.44) | TSHRCYP3A4MEN1KMT2AALDH1A1 | |
| SCHEMBL25134468 | 0.74 | TSHR (0.44) | TSHRTP53CYP3A4AHRMEN1 | |
| SCHEMBL2646961 | 0.74 | TSHR (0.44) | TSHRTP53CYP3A4MEN1KMT2A | |
| SCHEMBL4495782 | 0.74 | TSHR (0.44) | TSHRTP53CYP3A4AHRMEN1 | |
| SCHEMBL15449818 | 0.74 | TSHR (0.44) | TSHRTP53CYP3A4AHRMEN1 | |
| SCHEMBL11457726 | 0.74 | MEN1 (0.39) | TSHRTP53CYP3A4MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0360829-B1 | DEHYDROBROMINATION OF SUBSTITUTED ALPHA-HALOCUMENE | DOWELANCO (US) | 1993-05-26 | — | — | EP | claimed |
| US-4594467-A | DEHYDROBROMINATING ALPH-BROMO-3,5-DICHLORO CUMENE WITH ALKALI METAL HYDROXIDE IN PRESENCE OF PHASE TRANSFER CATALYST | BAYER AKTIENGESELLSCHAFT (DE) | 1986-06-10 | — | — | US | claimed |
| EP-0360829-B1 | DEHYDROBROMINATION OF SUBSTITUTED ALPHA-HALOCUMENE | DOWELANCO (US) | 1993-05-26 | — | — | EP | disclosed |
| EP-0360829-A1 | DEHYDROBROMINATION OF SUBSTITUTED ALPHA-HALOCUMENE. | DOW CHEMICAL CO (US) | 1990-04-04 | — | — | EP | disclosed |
| US-4861927-A | Dehydrohalogenation of ring-halogenated α-halocumenes | THE DOW CHEMICAL COMPANY (US) | 1989-08-29 | — | — | US | disclosed |
| WO-1988009319-A1 | DEHYDROBROMINATION OF SUBSTITUTED alpha-HALOCUMENE | THE DOW CHEMICAL COMPANY (US) | 1988-12-01 | — | — | WO | disclosed |
| US-4760209-A | Isopropylation, isomerization, bromination and dehydrobromination | BAYER AKTIENGESELLSCHAFT (DE) | 1988-07-26 | — | — | US | disclosed |
| US-4594467-A | DEHYDROBROMINATING ALPH-BROMO-3,5-DICHLORO CUMENE WITH ALKALI METAL HYDROXIDE IN PRESENCE OF PHASE TRANSFER CATALYST | BAYER AKTIENGESELLSCHAFT (DE) | 1986-06-10 | — | — | US | disclosed |
| US-4594467-A | DEHYDROBROMINATING ALPH-BROMO-3,5-DICHLORO CUMENE WITH ALKALI METAL HYDROXIDE IN PRESENCE OF PHASE TRANSFER CATALYST | BAYER AKTIENGESELLSCHAFT (DE) | 1986-06-10 | — | — | US | disclosed |
| US-4087473-A | Preferential aliphatic halogenation of ar-substituted alkylbenzenes | THE DOW CHEMICAL COMPANY (US) | 1978-05-02 | — | — | US | disclosed |
| US-4087473-A | Preferential aliphatic halogenation of ar-substituted alkylbenzenes | THE DOW CHEMICAL COMPANY (US) | 1978-05-02 | — | — | US | disclosed |